Peritoneal Surface Malignancy Treatment Program

 

The peritoneum is the membrane that lines the abdominal cavity. Peritoneal surface malignancy is a term for a variety of tumors that develop in the membrane or in organs within the cavity.

At one time, these tumors were considered incurable. Today, surgical oncologists at The University of Kansas Hospital are providing new treatment options. These include an aggressive procedure called cytoreductive surgery to remove the tumors, followed by hyperthermic intraperitoneal chemotherapy.

During cytoreductive surgery, all visible tumors are removed from the abdomen. Then, heated fluid containing chemotherapy (an anti-cancer drug) is circulated through the stomach cavity.

Studies have shown this combination treatment to be more effective than surgery alone, reducing the risk of recurrence. The technique has also been shown to dramatically reduce pain.

Only a few surgeons in the nation have the training and experience to offer this treatment.

Shield
Magnet recognized
By the American Nurses Credentialing Center.
Shield
U.S. News & World Report 
Ranked among the nation's best hospitals. 
Shield
Top academic medical center
Earned Vizient's 2018 Bernard A. Birnbaum, MD, Quality Leadership Award; ranked 5th out of 99 academic medical centers studied.